-
Sanofi’s Qfitlia Approved by FDA for Hemophilia A and B Prophylaxis
•
France-based Sanofi (EPA: SAN, NASDAQ: SNY) has announced receiving marketing approval from the US Food and Drug Administration (FDA) for Qfitlia (fitusiran). This antithrombin-lowering (AT) therapy is now approved for routine prophylaxis to prevent or reduce bleeding episodes in adult and pediatric patients (aged 12 or older) with hemophilia A…
-
Siemens Healthineers Posts Strong Q1 Results with 5.7% Revenue Growth
•
Germany-based Siemens Healthineers AG (ETR: SHL) released its results for the first quarter of fiscal year 2025, ended December 31, 2024. The company showcased an excellent equipment book-to-bill ratio of 1.21 and comparable revenue growth of 5.7%. This marks a strong start to the fiscal year, driven by growth across…
-
Siemens Lays Foundation for New Medical Equipment Base in Shenzhen
•
Siemens (Shenzhen) Magnetic Resonance Co., Ltd., a wholly-owned subsidiary of Siemens Ltd., China, has officially laid the foundation for its new high-end medical equipment R&D and manufacturing base project in Nanshan District, Shenzhen. This significant investment marks a major expansion of Siemens’ capabilities in the region. Project Details and TimelineThe…
-
Siemens Healthineers AG Acquires Advanced Accelerator Applications to Boost PETNET Solutions
•
Germany-based Siemens Healthineers AG (ETR: SHL) has announced the completion of its acquisition of Advanced Accelerator Applications (AAA) Molecular Imaging from Novartis (NYSE: NVS). This strategic move is anticipated to significantly enhance Siemens’ PETNET Solutions sector, strengthening its position in the field of positron emission tomography (PET) and radiopharmaceuticals. Enhancing…
-
Siemens Healthineers AG Reports Fiscal 2024 Results with Targeted Revenue Growth
•
Germany-based medical device giant Siemens Healthineers AG (ETR: SHL) has released its financial results for the fourth quarter of fiscal 2024, ended September 30, 2024, and the full fiscal year 2024. The company achieved its targets for revenue growth and earnings per share for FY2024, demonstrating resilience amidst challenging market…
-
Siemens Healthineers’ 7T MRI System Terra. X Receives NMPA Marketing Approval
•
Siemens Healthineers AG has secured marketing approval from China’s National Medical Products Administration (NMPA) for its Magnetom Terra X, a localized next-generation 7T magnetic resonance imaging (MRI) system. This marks a significant advancement in medical imaging technology within the Chinese market. Terra. X, the first domestically produced 7T clinical MRI…
-
Siemens Healthineers Partners with Cedars-Sinai to Boost Medical Cooperation and Education
•
Siemens Healthineers AG, a global leader in medical technology, has announced a strategic partnership with Cedars-Sinai Medical Center, a prestigious non-profit academic medical institution with a century-long history. Through this alliance, Siemens Healthineers’ China division and Cedars-Sinai will embark on a collaborative journey aimed at enhancing international medical exchange and…
-
Siemens Healthineers and Ruijin Hospital Collaborate to Build Medical Digital Human Metaverse
•
Siemens Healthineers AG, the German medical technology major, has entered into a strategic partnership with Ruijin Hospital, a Class 3A teaching hospital based in Shanghai. The collaboration aims at developing “Medical digital human metaverse application scenarios,” marking a significant step in the integration of metaverse technology into healthcare. Siemens Healthineers…
-
Siemens Healthineers Reports 3% YOY Growth in Q2 2024 Fiscal Report Amidst Challenging Comparison
•
Germany’s medical technology leader Siemens Healthineers AG (ETR: SHL) has reported its financial results for the second quarter of fiscal 2024, which concluded on March 31, 2024. The company achieved total revenues of EUR 5.44 billion (USD 5.85 billion), marking a growth of 3% year-on-year (YOY) at constant currency. Siemens…
-
Siemens Healthineers AG Forges Expanded Partnership with Xi’an Daixing Hospital
•
Germany’s Siemens Healthineers AG (ETR: SHL) has entered into an eight-year value partnership with Xi’an Daixing Hospital, a top-tier Class 3A medical institution located in Northwestern China. The collaboration aims to delve into various areas, including the construction of an innovative ecosystem, talent development, international exchange initiatives, scientific research consultation,…
-
Siemens Healthineers AG Partners with Haidian District Government to Boost Medical Innovation in Beijing
•
Siemens Healthineers AG (ETR: SHL), a leading medical technology company based in Germany, has entered into a strategic partnership with the Haidian district government in Beijing. The collaboration aims to foster international medical talent cultivation, develop a medical technology innovation ecosystem, and enhance medical industry translation cooperation, among other initiatives.…
-
Shanghai Electric Group and Siemens Healthineers Unveil Ultramarine Series Medical Imaging Devices
•
Shanghai Electric Group, a major player in China’s electrical equipment industry, has partnered with Siemens Healthineers, the German medical technology giant, to launch the Ultramarine series of medical imaging products. The new lineup features three domestically produced medical imaging devices: the Ultramarine 1.5T MRI, Ultramarine 128 CT, and Ultramarine 32…
-
Siemens Healthineers and Siemens China Partner with Fudan Hospital Logistic Service on Green Imaging Centers
•
Germany-based Siemens Healthineers AG, along with its subsidiary Siemens China, has entered into a strategic partnership with Fudan Hospital Logistic Service Co., Ltd. The collaboration aims to delve into product, technology, and service cooperation, with a focus on jointly creating innovative green imaging centers. Under the terms of the agreement,…
-
Siemens Healthineers Posts 5.7% Q1 2024 Sales Growth, Exceeds Pre-Pandemic Levels
•
Siemens Healthineers AG (ETR: SHL), based in Germany, has released its quarterly report for the first quarter of the fiscal year 2024, concluded on December 31, 2023. On a currency-adjusted basis, sales increased by 5.7% to EUR 5.18 billion (USD 5.6 billion). When excluding the impact of COVID-19-related sales, the…
-
Siemens Healthineers AG and Shandong First Medical University’s College of Radiology Collaborate on Medical Imaging Metaverse
•
Siemens Healthineers AG (ETR: SHL), a leading life sciences company based in Germany, has entered into a strategic partnership with the College of Radiology at Shandong First Medical University. The collaboration aims to encompass several key initiatives: The duo will jointly construct China’s inaugural “Medical Imaging Metaverse Immersive Teaching and…
-
Sun Yat-sen Memorial Hospital Partners with Siemens Healthineers on Metaverse Visualization Surgery
•
China’s Sun Yat-sen Memorial Hospital, affiliated with Sun Yat-sen University, has entered into a strategic partnership with Germany-based life sciences giant Siemens Healthineers AG (ETR: SHL) at the 6th China International Import Expo (CIIE) in Shanghai. The collaboration focuses on the science research, application, and translation of metaverse visualization surgery,…
-
Siemens Healthineers Reports 3.6% YOY Revenue Growth in Q3 2023 Financials
•
Germany-based life sciences giant Siemens Healthineers AG (ETR: SHL) has released its financial results for the third quarter of its 2023 fiscal year, which ended on June 30. The company reported global revenues of EUR 5.2 billion (USD 5.6 billion), marking a 3.6% year-on-year (YOY) growth in constant exchange rate…
-
Siemens Healthineers and China Chest Pain Center Launch Smart Training Program
•
German healthcare giant Siemens Healthineers (ETR: SHL) has partnered with the China Chest Pain Center to launch the “Rising Star smart chest pain center standardized construction training program.” This initiative is designed to enhance the standardized construction of chest pain treatment processes and improve clinical intervention diagnosis and treatment capabilities.…
-
Pudong New Area Grants Duty-Free Import Qualifications to Seven Companies
•
Seven companies have been awarded scientific and technological innovation duty-free import qualification designations by the foreign R&D center in Pudong New Area. Among the awardees are Fosun Kite Biotechnology Co., Ltd, a joint venture (JV) between Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196) and Gilead subsidiary Kite Pharma, as…
-
Siemens Healthineers Reports Q1 Revenue Drop Amid COVID-19 Impact
•
Germany-based medical device giant Siemens Healthineers AG has released its fiscal year 2023 Q1 financial report for the three-month period ending December 31, 2022. Global revenues were down 4.5% to EUR 5.077 billion (USD 5.5 billion), primarily reflecting the slowing demand for COVID-19 antigen testing. Business Group PerformanceExcluding COVID-19 antigen…
